繁体中文
设为首页
加入收藏
当前位置:药品说明书与价格首页 >> 精神心理 >> 多动症 >> 药品推荐 >> Cotempla XR-ODT Tablets(Methylphenidate 哌醋甲酯缓释口服崩解片)

Cotempla XR-ODT Tablets(Methylphenidate 哌醋甲酯缓释口服崩解片)

2017-11-09 09:57:20  作者:新特药房  来源:互联网  浏览次数:0  文字大小:【】【】【
简介:美国FDA批准Cotempla XR-ODT为第一个也是唯一的用于治疗注意力缺陷/多动症近日,美国食品和药物管理局(FDA)批准了第一个也是唯一的哌醋甲酯缓释口服崩解片剂Cotempla XR-ODT,用于治疗注意力缺陷/多动症(ADH ...
美国FDA批准Cotempla XR-ODT为第一个也是唯一的用于治疗注意力缺陷/多动症
近日,美国食品和药物管理局(FDA)批准了第一个也是唯一的哌醋甲酯缓释口服崩解片剂Cotempla XR-ODT,用于治疗注意力缺陷/多动症(ADHD) 6至17岁的患者。
适应症:
Cotempla XR-ODT是一种中枢神经系统(CNS)兴奋剂,用于治疗6至17岁儿童ADHD。
剂量/给药:6至17岁的儿科患者建议起始剂量为17.3毫克,每天早晨口服一次。剂量可以每周增加8.6mg至17.3mg每天增加。不建议每日剂量高于51.8毫克。建议患者持续食用或不食用Cotempla XR-ODT。
不良反应:
根据其他哌甲酯产品的累积数据,最常见的(安慰剂的5%和2倍)不良反应是食欲下降,失眠,恶心,呕吐,消化不良,腹痛,体重减轻,焦虑,头晕,烦躁不安,影响不稳定,心动过速和血压升高。
Cotempla XR ODT(Methylphenidate Extended-Release Orally Disintegrating Tablets)
COTEMPLA XR-ODT CII
Generic Name and Formulations:
Methylphenidate 8.6mg, 17.3mg, 25.9mg; ext-rel orally disintegrating tabs.
Company:
Neos Therapeutics
Indications for COTEMPLA XR-ODT:
Attention deficit hyperactivity disorder.
Adults and Children:
<6yrs: not established. Place tab on tongue and allow it to disintegrate; do not chew or crush. 6–17yrs: Individualize. Initially 17.3mg once daily in the AM. May titrate in increments of 8.6–17.3mg weekly; max 51.8mg daily. Discontinue if no improvement seen after dose adjustment over 1 month.
Contraindications:
During or within 14 days of MAOIs.
Warnings/Precautions:
High potential for abuse and dependence; monitor. Increased risk of sudden death, stroke, and MI; assess for presence of cardiac disease before initiating. Avoid in known structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, coronary artery disease, other cardiac problems. Pre-existing psychotic disorder. Bipolar disorder. Screen for risk factors in developing a manic episode prior to initiating. Consider discontinuing if psychotic/manic symptoms occur. Peripheral vasculopathy, including Raynaud’s phenomenon; monitor for digital changes. Monitor growth (in children), BP, HR. Reduce dose or discontinue if paradoxical aggravation of symptoms occur. Reevaluate periodically. Pregnancy. Nursing mothers: monitor infants.
Interactions:
See Contraindications. Concomitant gastric pH modulators (eg, omeprazole, famotidine, sodium bicarbonate): not recommended.
Pharmacological Class:
CNS stimulant.
Adverse Reactions:
Appetite decreased, insomnia, nausea, vomiting, dyspepsia, abdominal pain, weight decreased, anxiety, dizziness, irritability, affect lability, tachycardia, BP increased; priapism.
Note:
Register pregnant patients exposed to Cotempla XR-ODT by calling (866) 961-2388.
Generic Availability:
NO
How Supplied:
Blister pack—30 (5x6)

责任编辑:p53


相关文章
Aptensio XR(盐酸哌甲酯缓释胶囊)
Concerta Tablets(盐酸哌甲酯片)
盐酸哌甲酯缓释片(methylphenidate,专注达,Concerta)
哌甲酯(methylphenidate)皮肤贴剂(Daytrana)
 

最新文章

更多

· Cotempla XR-ODT Tablet...
· Intuniv 24HR(guanfacin...
· Dyanavel XR (amphetami...
· Concerta Tablets(盐酸...
· QUILLIVANT XR(盐酸哌甲...
· 右旋硫酸缓释胶囊(amph...
· 二甲磺酸赖右苯丙胺胶囊...
· 口服液 静灵口服液-为纯中药制剂...
· 盐酸哌甲酯缓释片(methy...
· 盐酸可乐定缓释片(Kapv...

推荐文章

更多

· Cotempla XR-ODT Tablet...
· Intuniv 24HR(guanfacin...
· Dyanavel XR (amphetami...
· Concerta Tablets(盐酸...
· QUILLIVANT XR(盐酸哌甲...
· 右旋硫酸缓释胶囊(amph...
· 二甲磺酸赖右苯丙胺胶囊...
· 口服液 静灵口服液-为纯中药制剂...
· 盐酸哌甲酯缓释片(methy...
· 盐酸可乐定缓释片(Kapv...

热点文章

更多

· Cotempla XR-ODT Tablet...